普洛药业(000739.SZ):控股股东一致行动人拟增持0.6亿元-1.2亿元公司股份

Core Viewpoint - Prolo Pharmaceutical (000739.SZ) announced that its controlling shareholder, Hengdian Group, through its action-in-concert party, Dongyang Hengdian Yushan Sports Leisure Co., Ltd. (referred to as "Yushan Sports"), has increased its shareholding in the company, indicating a positive outlook on the company's future performance [1] Group 1 - Yushan Sports acquired 1,653,500 shares of Prolo Pharmaceutical on January 13, 2026, representing 0.14% of the company's total share capital, with a total investment of approximately RMB 28,695,970 [1] - Following this transaction, the combined shareholding of the controlling shareholder and its action-in-concert parties reached 52.03%, triggering a change in equity that touches the 1% integer multiple [1] Group 2 - Yushan Sports plans to further increase its shareholding within six months starting from January 13, 2026, with a minimum investment of RMB 60 million and a maximum of RMB 120 million, including the amount already invested [1]